Chunlin Zhou - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Chunlin Zhou

Showing results (61-70 of 64) with videos related to

Pageof 7

Sort By:

You have reached the last page of results.This site can display upto 64 results.

Experimental Hematology & Oncology|September 17, 2021

Efficacy of combination of venetoclax with azacitidine or chemotherapy in refractory/relapse acute leukemias of ambiguous lineage, not otherwise specifiedKaiqi Liu, Yan Li, Shaowei Qiu, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 8, 2020

Randomized Trial of Intermediate-dose Cytarabine in Induction and Consolidation Therapy in Adults with Acute Myeloid LeukemiaHui Wei, Ying Wang, Robert Peter Gale, et al.

British Journal of Haematology|March 11, 2022

The prognostic factors in acute myeloid leukaemia with double-mutated CCAAT/enhancer-binding protein alpha (CEBPAdm)Hui Wei, Chunlin Zhou, Bingcheng Liu, et al.

Journal of Hematology & Oncology|September 7, 2020

Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemiaRunxia Gu, Fang Liu, Dehui Zou, et al.

Pageof 7

Search research articles

Showing results (61-70 of 64) with videos related to

Sort By:

Pageof 7

You have reached the last page of results.This site can display upto 64 results.

Experimental Hematology & Oncology|September 17, 2021

Efficacy of combination of venetoclax with azacitidine or chemotherapy in refractory/relapse acute leukemias of ambiguous lineage, not otherwise specifiedKaiqi Liu, Yan Li, Shaowei Qiu, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 8, 2020

Randomized Trial of Intermediate-dose Cytarabine in Induction and Consolidation Therapy in Adults with Acute Myeloid LeukemiaHui Wei, Ying Wang, Robert Peter Gale, et al.

British Journal of Haematology|March 11, 2022

The prognostic factors in acute myeloid leukaemia with double-mutated CCAAT/enhancer-binding protein alpha (CEBPAdm)Hui Wei, Chunlin Zhou, Bingcheng Liu, et al.

Journal of Hematology & Oncology|September 7, 2020

Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemiaRunxia Gu, Fang Liu, Dehui Zou, et al.

Pageof 7